Lipid Management Beyond Statins
Transcription
Lipid Management Beyond Statins
Lipid Management Beyond Statins: Biologic Basis, New Clinical Evidence, and Strategies Complimentary CME/CE Dinner Friday, June 12, 2015 6:30 pm – 7:00 pm 7:00 pm – 9:15 pm Registration and Dinner CME/CE Activity Palmer House Hilton State Ballroom, 4th Floor 17 East Monroe Street Chicago, IL 60603 This activity is jointly provided by Postgraduate Institute for Medicine This activity is jointly provided by the National Lipid Association. Medtelligence SM Supported by an educational grant from Amarin Pharma Inc. Program Overview Statins provide proven cardiovascular benefit in broad patient categories. Yet, even with guideline-mandated statin management, substantial residual risk remains for many dyslipidemic patients. Fibrates, nicotinic acids, OM3s, cholesterol absorption inhibitors? What is the biologic plausibility of each class for cardiovascular benefit? What is the clinical evidence? Are there agents of choice for particular forms of dyslipidemia? How much might severity of dyslipidemia or co-morbidities such as CAD, diabetes, or obesity factor into decision-making? This engaging educational activity will provide a rigorous review of these questions with an emphasis on offering expert practical commentary for clinicians who treat patients at high risk for CV events. Target Audience Physicians, NPs/PAs, pharmacists, RNs, Advance Practice Registered Nurses, and registered dietitians with an interest in lipid management and CV disease risk reduction Learning Objectives After completing this activity, the participant should be better able to: • Relate the key biologic pathways responsible for atherosclerotic disease and the mechanisms of therapies that inhibit its development • Discuss the current clinical trial evidence of therapies that have been used as add-on therapy to statins to reduce CV events • Incorporate risk assessment, guideline recommendations, and patient-centered approaches for add-on therapeutic decision-making for patients at high risk for CV events • For Registered Nurses and Nurse Practitioners only: – Provide appropriate care and counsel for patients and their families Friday, June 12, 2015 Palmer House Hilton 6:30 pm – 7:00 pm 7:00 pm – 9:15 pm State Ballroom, 4th Floor 17 East Monroe Street, Chicago, IL 60603 Registration and Dinner CME/CE Activity Agenda 6:30 pm Registration and Dinner 7:00 Welcome and Opening Remarks Peter Libby, MD, Chair 7:10 Mechanistic Insights Into Treatments to Reduce Atherosclerosis Beyond Statins Peter Libby, MD 7:35 The Evidence for Add-on to Statin Therapy to Reduce CV Events Michael Miller, MD 8:00 Risk, Evidence, and Patient Preference in Guiding Add-on Therapy Harold Bays, MD 8:25 Panel Discussion and Q&A All Faculty 8:45 Cases for Discussion All Faculty 9:15 pm Adjourn Lipid Management Beyond Statins: Biologic Basis, New Clinical Evidence, and Strategies Faculty Peter Libby, MD, FACC, Chair Cardiovascular Medicine Brigham and Women’s Hospital Mallinckrodt Professor of Medicine Harvard Medical School Boston, MA Harold E. Bays, MD, FTOS, FACC, FACE, FNLA Medical Director / President L-MARC Research Center Louisville, KY Michael Miller, MD, FACC, FAHA Professor of Cardiovascular Medicine, Epidemiology & Public Health University of Maryland School of Medicine Director, Center for Preventive Cardiology University of Maryland Medical Center Baltimore, MD Attendance Is Limited! Registration for this event must be submitted online at: http://events.medtelligence.net/nla2015.html Credit Designation CME credit provided by the National Lipid Association Physicians This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Lipid Association and Medtelligence. The National Lipid Association is accredited by the ACCME to provide continuing medical education for physicians. The National Lipid Association designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Physician Assistants NCCPA accepts AMA PRA Category I Credit ™ from organizations accredited by ACCME. Dietitians The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 2 Continuing Professional Education Units (CPEUs) for completion of this program. CDR Accredited Provider #NL0002. CE credit provided by Postgraduate Institute for Medicine Pharmacists Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Universal Activity Number 0809-9999-185-L01-P (Application) Postgraduate Institute for Medicine designates this continuing education activity for 2.25 contact hours (.225 CEUs) of the Accreditation Council for Pharmacy Education. Nursing This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine. Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. Criteria for Success Statements of credit will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. If you have questions about this CME/CE activity, please contact the NLA at [email protected]. Please claim credit by July 10, 2015. For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks. Disclosure Statement It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose. Commercial Support Full notification of commercial support will be provided in the activity syllabus. Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Chris Archibald prior to the live event at [email protected]. There is no fee for this educational activity.